Medical Research
(H30)
IRS Verified
DX Registered
NEUROBLASTOMA CHILDRENS CANCER SOCIETY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$30K
Total Revenue
$39K
Total Expenses
$40K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
0.0%
Operating Reserve
12.19x
Liability-to-Asset
0.0%
Revenue Diversification
72.0%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $30K | $39K | $40K | 100.0% | 0 |
| 2022 | $35K | $42K | N/A | — | 0 |
| 2021 | $41K | $41K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.